Allergan plc. (AGN) stock is expected to deviate a maximum of $51.4 from the average target price of $294.64 for the short term period. 11 Street Experts have initiated coverage on the stock with the most promising target being $400 and the most muted being $232.
Allergan plc. (AGN), A reduction of 1,426,190 shares or 19.7% was observed in the short interest of Allergan plc. The interest on June 30,2016 came in at 5,800,619 shares and as per the average daily trading of 3,566,673 shares, the days to cover are 2. The reduced interest is 1.5% of the floated shares. The data of June 15,2016 put the interest at 7,226,809 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.
Also, Equity analysts at the Brokerage firm Piper Jaffray downgrades its rating on Allergan plc. (NYSE:AGN). The rating major has initiated the coverage with neutral rating on the shares. Earlier, the shares were rated a Overweight by the brokerage firm. The Analysts at Piper Jaffray lowers the price target from $311 per share to $238 per share. The rating by the firm was issued on April 18, 2016.
Allergan plc. (NYSE:AGN): stock turned positive on Thursday. Though the stock opened at $243.59, the bulls momentum made the stock top out at $244.95 level for the day. The stock recorded a low of $241.17 and closed the trading day at $244.21, in the green by 1.26%. The total traded volume for the day was 2,136,130. The stock had closed at $241.17 in the previous days trading.